126.3K XNAS Volume
XNAS 24 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 11,134 | 20,023 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 03 Apr 2025 | 11,134 | 120,670 | - | 2.1 | 23,381 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.67 per share. | 17 Mar 2025 | 1,784 | 109,536 | - | 10.7 | 19,035 | Common Stock |
| Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 116,200 | 441,953 | - | 0 | Common Stock | |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 17,566 | 424,387 | - | 11.7 | 205,146 | Common Stock |
| Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 173,400 | 173,400 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 42,400 | 116,249 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 4,929 | 111,320 | - | 11.7 | 57,564 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 63,300 | 63,300 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 60,800 | 185,949 | - | 0 | Common Stock | |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 5,144 | 180,805 | - | 11.7 | 60,075 | Common Stock |
| Nathan J. Dowden | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 90,800 | 90,800 | - | - | Stock Option (Right to Buy) | |
| Natarajan Sethuraman | President, Research & Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 60,800 | 205,797 | - | 0 | Common Stock | |
| Natarajan Sethuraman | President, Research & Develop. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 6,138 | 199,659 | - | 11.7 | 71,683 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 90,800 | 90,800 | - | - | Stock Option (Right to Buy) | |
| J. Kory Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 1,000 | 36,157 | - | - | Stock Option (Right to Buy) | |
| Wentworth Kory J. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 29 Nov 2024 | 5,000 | 78,849 | - | 2.1 | 10,500 | Common Stock |
| Sethuraman Natarajan | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 29 Nov 2024 | 11,703 | 144,997 | - | 20.1 | 235,786 | Common Stock |
| J. Kory Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2024 | 5,000 | 31,157 | - | - | Stock Option (Right to Buy) | |
| J. Kory Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 29 Nov 2024 | 1,000 | 74,849 | - | 2.1 | 2,100 | Common Stock |
| Kory Wentworth J. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 29 Nov 2024 | 5,000 | 73,849 | - | 20.0 | 99,978 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.26 per share. | 29 Nov 2024 | 4,088 | 156,700 | - | 20.3 | 82,834 | Common Stock |
| Sethuraman Natarajan | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 29 Nov 2024 | 100 | 160,788 | - | 20 | 2,000 | Common Stock |
| Wentworth Kory J. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.97 per share. | 29 Nov 2024 | 1,000 | 73,849 | - | 20.0 | 19,970 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 6,000 | 37,157 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 11 Nov 2024 | 6,000 | 82,486 | - | 2.1 | 12,600 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.98 per share. | 11 Nov 2024 | 8,637 | 73,849 | - | 20.0 | 172,562 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 11 Nov 2024 | 2,700 | 160,888 | - | 20.0 | 54,109 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 11 Nov 2024 | 1,409 | 163,588 | - | 20.0 | 28,191 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.02 per share. | 04 Nov 2024 | 749 | 182,467 | - | 18.0 | 13,498 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 04 Nov 2024 | 9,554 | 167,742 | - | 18.7 | 178,752 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 19.32 per share. | 04 Nov 2024 | 2,745 | 164,997 | - | 19.3 | 53,024 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 Nov 2024 | 5,171 | 177,296 | - | 18.2 | 94,006 | Common Stock |
| Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 16 Oct 2024 | 600 | 183,216 | - | 18 | 10,800 | Common Stock |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 26 Sep 2024 | 847 | 125,149 | - | 16 | 13,552 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.97 per share. | 09 Sep 2024 | 3,195 | 76,486 | - | 15.0 | 47,832 | Common Stock |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 06 Sep 2024 | 1,904 | 125,996 | - | 15.1 | 28,690 | Common Stock |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 15.20 per share. | 06 Sep 2024 | 399 | 127,900 | - | 15.2 | 6,063 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 06 Sep 2024 | 2,642 | 183,816 | - | 15.1 | 39,862 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 06 Sep 2024 | 600 | 186,458 | - | 15.2 | 9,141 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 2,328 | 332,147 | - | 15.8 | 36,692 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 826 | 325,753 | - | 15.1 | 12,494 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 4,744 | 326,579 | - | 15.4 | 73,169 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. | 03 Sep 2024 | 72 | 331,323 | - | 17.7 | 1,275 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 03 Sep 2024 | 752 | 331,395 | - | 16.9 | 12,728 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 462 | 80,950 | - | 15.8 | 7,282 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 165 | 79,681 | - | 15.1 | 2,496 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 941 | 79,846 | - | 15.4 | 14,513 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. | 03 Sep 2024 | 14 | 80,787 | - | 17.7 | 248 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 03 Sep 2024 | 149 | 80,801 | - | 16.9 | 2,522 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. | 03 Sep 2024 | 156 | 129,468 | - | 16.9 | 2,640 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 171 | 128,299 | - | 15.1 | 2,587 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 983 | 128,470 | - | 15.4 | 15,161 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.73 per share. | 03 Sep 2024 | 15 | 129,453 | - | 17.7 | 266 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 483 | 129,624 | - | 15.8 | 7,613 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 469 | 188,345 | - | 15.8 | 7,392 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 167 | 187,058 | - | 15.1 | 2,526 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 955 | 187,225 | - | 15.4 | 14,729 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. | 03 Sep 2024 | 14 | 188,180 | - | 17.7 | 248 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 03 Sep 2024 | 151 | 188,194 | - | 16.9 | 2,556 | Common Stock |
| Nathan J. Dowden | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 16 Aug 2024 | 20,000 | 157,204 | - | 1.7 | 34,800 | Common Stock |
| Nathan J. Dowden | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 20,000 | 64,831 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 16 Aug 2024 | 502 | 130,107 | - | 16.7 | 8,382 | Common Stock |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 16.26 per share. | 16 Aug 2024 | 26,595 | 130,609 | - | 16.3 | 432,419 | Common Stock |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 12 Jul 2024 | 1,600 | 334,475 | - | 17.8 | 28,497 | Common Stock |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 300 | 336,075 | - | 18 | 5,400 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 638 | 188,814 | - | 18 | 11,484 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 600 | 189,452 | - | 18 | 10,800 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.95 per share. | 08 Jul 2024 | 1,758 | 81,412 | - | 14.9 | 26,282 | Common Stock |
| Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 13 Jun 2024 | 1,000 | 336,375 | - | 16.2 | 16,174 | Common Stock |
| Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Gina Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Peter S. Kim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 11,918 | 0 | - | - | Stock Option (Right to Buy) | |
| Peter S. Kim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.06 per share. | 03 Jun 2024 | 11,918 | 104,330 | - | 6.1 | 72,223 | Common Stock |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 May 2024 | 1,800 | 338,575 | - | 15 | 27,000 | Common Stock |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 16 May 2024 | 1,200 | 337,375 | - | 15.1 | 18,129 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 16 May 2024 | 9,675 | 190,052 | - | 15.2 | 146,944 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 May 2024 | 1,000 | 208,032 | - | 15 | 15,000 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 16 May 2024 | 8,305 | 199,727 | - | 15.1 | 125,751 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.59 per share. | 14 May 2024 | 25,000 | 92,412 | - | 14.6 | 364,673 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.25 per share. | 08 May 2024 | 2,200 | 67,412 | - | 14.2 | 31,341 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.04 per share. | 08 May 2024 | 2,276 | 65,212 | - | 14.0 | 31,965 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.57 per share. | 08 Apr 2024 | 2,600 | 62,936 | - | 13.6 | 35,290 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.75 per share. | 28 Mar 2024 | 1,512 | 60,336 | - | 13.8 | 20,794 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.64 per share. | 22 Mar 2024 | 2,750 | 58,824 | - | 13.6 | 37,509 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.36 per share. | 22 Mar 2024 | 3,180 | 56,074 | - | 13.4 | 42,472 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.76 per share. | 22 Mar 2024 | 3,118 | 52,894 | - | 13.8 | 42,901 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 12.66 per share. | 19 Mar 2024 | 900 | 47,944 | - | 12.7 | 11,397 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.24 per share. | 19 Mar 2024 | 704 | 49,776 | - | 13.2 | 9,318 | Common Stock |
| Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 12.66 per share. | 19 Mar 2024 | 1,128 | 49,072 | - | 12.7 | 14,281 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 9,000 | 43,157 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 15 Mar 2024 | 9,000 | 83,170 | - | 2.1 | 18,900 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 06 Mar 2024 | 4,086 | 74,170 | - | 12.3 | 50,285 | Common Stock |
| Nathan J. Dowden | President & COO | Sale of securities on an exchange or to another person at price $ 12.32 per share. | 06 Mar 2024 | 1,826 | 137,204 | - | 12.3 | 22,499 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 5,049 | 340,375 | - | 12.3 | 61,996 | Common Stock |
| Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 158,500 | 158,500 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 104,700 | 347,979 | - | 0 | Common Stock | |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 1,164 | 346,815 | - | 12.4 | 14,460 | Common Stock |
| Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 1,391 | 345,424 | - | 13.4 | 18,594 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 1,471 | 78,256 | - | 12.3 | 18,062 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 46,800 | 46,800 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,900 | 80,471 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 339 | 80,132 | - | 12.4 | 4,211 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 405 | 79,727 | - | 13.4 | 5,414 | Common Stock |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 343 | 140,925 | - | 12.4 | 4,261 | Common Stock |
| Nathan J. Dowden | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 60,000 | 141,268 | - | 0 | Common Stock | |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 1,486 | 139,030 | - | 12.3 | 18,246 | Common Stock |
| Nathan J. Dowden | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 50,100 | 50,100 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 33,100 | 81,268 | - | 0 | Common Stock | |
| Nathan J. Dowden | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 409 | 140,516 | - | 13.4 | 5,467 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 1,505 | 209,032 | - | 12.3 | 18,480 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 44,100 | 211,298 | - | 0 | Common Stock | |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 347 | 210,951 | - | 12.4 | 4,311 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 414 | 210,537 | - | 13.4 | 5,534 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 66,800 | 66,800 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 15 Feb 2024 | 1,000 | 243,279 | - | 15 | 15,000 | Common Stock |
| Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 16 Jan 2024 | 1,000 | 244,279 | - | 16.0 | 15,990 | Common Stock |
| Kory Wentworth J. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Dec 2023 | 10,206 | 59,777 | - | 2.1 | 21,433 | Common Stock |
| Wentworth J. Kory | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 94 | 52,157 | - | - | Stock Option (Right to Buy) | |
| Kory Wentworth J. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 10,206 | 52,251 | - | - | Stock Option (Right to Buy) | |
| Wentworth Kory J. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 21 Dec 2023 | 3,677 | 49,571 | - | 16.5 | 60,611 | Common Stock |
| Kory Wentworth J. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 2,200 | 62,457 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Dec 2023 | 2,200 | 51,771 | - | 2.1 | 4,620 | Common Stock |
| J. Kory Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 21 Dec 2023 | 6,529 | 53,248 | - | 15.2 | 99,513 | Common Stock |
| J. Wentworth Kory | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Dec 2023 | 94 | 49,665 | - | 2.1 | 197 | Common Stock |
| Wentworth Kory J. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 21 Dec 2023 | 94 | 49,571 | - | 16.7 | 1,567 | Common Stock |
| Wentworth J. Kory | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 21 Dec 2023 | 2,200 | 49,571 | - | 15.1 | 33,155 | Common Stock |
| Doshi Dipal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Dec 2023 | 1,000 | 245,279 | - | 15 | 15,000 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.23 per share. | 13 Nov 2023 | 1,000 | 246,279 | - | 16.2 | 16,230 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 14 Aug 2023 | 1,000 | 201,069 | - | 15.7 | 15,671 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 6,898 | 88,012 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 9,464 | 94,910 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 10,348 | 104,374 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 02 Aug 2023 | 6,898 | 27,130 | - | 14.1 | 97,521 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 6,898 | 34,028 | - | 2.1 | 14,486 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 02 Aug 2023 | 9,464 | 27,130 | - | 14.7 | 139,530 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 9,464 | 36,594 | - | 2.1 | 19,874 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.82 per share. | 02 Aug 2023 | 68 | 27,130 | - | 16.8 | 1,144 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 02 Aug 2023 | 1,000 | 27,198 | - | 16.0 | 16,012 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Aug 2023 | 10,348 | 37,478 | - | 2.1 | 21,731 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 02 Aug 2023 | 9,280 | 28,198 | - | 15.1 | 140,013 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 10 Jul 2023 | 6,116 | 36,747 | - | 18.0 | 109,958 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 3,884 | 64,657 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 6,116 | 68,541 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 10 Jul 2023 | 3,884 | 36,747 | - | 18.0 | 69,904 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 10 Jul 2023 | 3,884 | 40,631 | - | 2.1 | 8,156 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 10 Jul 2023 | 6,116 | 42,863 | - | 2.1 | 12,844 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 10 Jul 2023 | 3,897 | 35,376 | - | 18.0 | 70,333 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 10 Jul 2023 | 3,200 | 39,273 | - | 18.0 | 57,605 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 10 Jul 2023 | 14,852 | 153,447 | - | 18.0 | 267,915 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 10 Jul 2023 | 3,026 | 168,299 | - | 18.0 | 54,474 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 8,790 | 74,657 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 29 Jun 2023 | 8,790 | 36,747 | - | 2.1 | 18,459 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 21 Jun 2023 | 8,593 | 36,864 | - | 14.8 | 127,519 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Jun 2023 | 17,500 | 45,457 | - | 2.1 | 36,750 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 21 Jun 2023 | 8,907 | 27,957 | - | 15.2 | 135,129 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2023 | 17,500 | 83,447 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 20 Jun 2023 | 7,097 | 42,473 | - | 16.0 | 113,700 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 14.94 per share. | 20 Jun 2023 | 8,885 | 49,570 | - | 14.9 | 132,704 | Common Stock |
| John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.71 per share. | 27 Apr 2023 | 2,000 | 202,069 | - | 13.7 | 27,422 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Apr 2023 | 2,092 | 204,069 | - | 18.0 | 37,675 | Common Stock |
| Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 17 Apr 2023 | 3,961 | 171,325 | - | 18.0 | 71,316 | Common Stock |
| Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.63 per share. | 27 Mar 2023 | 1,800 | 256,011 | - | 14.6 | 26,333 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 27 Mar 2023 | 200 | 255,811 | - | 15.5 | 3,102 | Common Stock |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 75,250 | 75,250 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 49,650 | 206,161 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 27,957 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 27,130 | - | 0 | Common Stock | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 58,455 | - | 0 | Common Stock | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 175,286 | - | 0 | Common Stock | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 28 Feb 2023 | 2,000 | 161,835 | - | 12 | 24,000 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jan 2023 | 2,000 | 163,835 | - | 12.0 | 24,001 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 09 Jan 2023 | 2,410 | 165,835 | - | 15.0 | 36,196 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 30 Dec 2022 | 5,200 | 15,516 | - | 13.4 | 69,932 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.80 per share. | 27 Dec 2022 | 600 | 182,235 | - | 14.8 | 8,879 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 27 Dec 2022 | 400 | 168,245 | - | 15.0 | 6,005 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 27 Dec 2022 | 4,521 | 168,645 | - | 15.0 | 67,852 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 27 Dec 2022 | 9,069 | 173,166 | - | 15.0 | 136,383 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.95 per share. | 08 Dec 2022 | 4,550 | 16,509 | - | 19.0 | 86,238 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 4,550 | 100,947 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 08 Dec 2022 | 4,550 | 21,059 | - | 2.1 | 9,555 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Dec 2022 | 2,910 | 19,419 | - | 2.1 | 6,111 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 200 | 105,497 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 2,910 | 105,697 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 02 Dec 2022 | 200 | 16,509 | - | 18.1 | 3,610 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 02 Dec 2022 | 200 | 16,709 | - | 2.1 | 420 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 02 Dec 2022 | 2,910 | 16,509 | - | 18.2 | 52,949 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.91 per share. | 28 Nov 2022 | 2,000 | 182,835 | - | 13.9 | 27,826 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 16 Nov 2022 | 200 | 16,709 | - | 2.1 | 420 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2022 | 200 | 108,607 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.10 per share. | 16 Nov 2022 | 200 | 16,509 | - | 18.1 | 3,620 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 24.05 per share. | 31 Oct 2022 | 2,100 | 45,283 | - | 24.0 | 50,495 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 25 Oct 2022 | 7,506 | 188,335 | - | 20.8 | 155,808 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.66 per share. | 25 Oct 2022 | 2,000 | 184,835 | - | 21.7 | 43,325 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 25 Oct 2022 | 1,500 | 186,835 | - | 21.5 | 32,251 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 25 Oct 2022 | 3,055 | 195,841 | - | 20.0 | 61,127 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.21 per share. | 25 Oct 2022 | 643 | 25,033 | - | 21.2 | 13,638 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 25 Oct 2022 | 4,960 | 25,676 | - | 2.1 | 10,416 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.13 per share. | 25 Oct 2022 | 100 | 20,716 | - | 22.1 | 2,213 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 25 Oct 2022 | 2,998 | 20,816 | - | 21.4 | 64,215 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.53 per share. | 25 Oct 2022 | 4,942 | 23,814 | - | 20.5 | 101,462 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 25 Oct 2022 | 8,040 | 28,756 | - | 2.1 | 16,884 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 4,960 | 114,722 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 8,040 | 119,682 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 25 Oct 2022 | 4,317 | 20,716 | - | 22.0 | 95,021 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 25 Oct 2022 | 3,034 | 53,697 | - | 20.1 | 60,996 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.85 per share. | 25 Oct 2022 | 900 | 47,383 | - | 21.9 | 19,669 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.97 per share. | 25 Oct 2022 | 5,414 | 48,283 | - | 21.0 | 113,526 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 20 Oct 2022 | 811 | 204,024 | - | 18.0 | 14,607 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 20 Oct 2022 | 1,241 | 198,896 | - | 19.6 | 24,380 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.90 per share. | 20 Oct 2022 | 1,101 | 200,137 | - | 18.9 | 20,809 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.28 per share. | 20 Oct 2022 | 2,786 | 201,238 | - | 18.3 | 50,917 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 20 Oct 2022 | 2,771 | 59,135 | - | 18.3 | 50,668 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 20 Oct 2022 | 1,302 | 56,731 | - | 19.7 | 25,595 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.88 per share. | 20 Oct 2022 | 1,102 | 58,033 | - | 18.9 | 20,807 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.07 per share. | 20 Oct 2022 | 905 | 61,906 | - | 18.1 | 16,357 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 26 Sep 2022 | 288 | 212,339 | - | 16.3 | 4,695 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 26 Sep 2022 | 3,085 | 204,835 | - | 15.2 | 46,997 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 26 Sep 2022 | 966 | 207,920 | - | 15.8 | 15,286 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 26 Sep 2022 | 3,453 | 208,886 | - | 15.0 | 51,934 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 26 Sep 2022 | 2,795 | 212,627 | - | 15.2 | 42,530 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 26 Sep 2022 | 2,768 | 21,016 | - | 15.2 | 42,131 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 26 Sep 2022 | 300 | 20,716 | - | 16.3 | 4,899 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 3,068 | 23,784 | - | 2.1 | 6,443 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,122 | 16,032 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 2,403 | 19,154 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,068 | 21,557 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 26 Sep 2022 | 3,122 | 20,716 | - | 15.2 | 47,610 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 3,122 | 23,838 | - | 2.1 | 6,556 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.31 per share. | 26 Sep 2022 | 2,403 | 20,716 | - | 15.3 | 36,789 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 26 Sep 2022 | 2,403 | 23,119 | - | 2.1 | 5,046 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 26 Sep 2022 | 215 | 62,811 | - | 16.2 | 3,493 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.32 per share. | 26 Sep 2022 | 1,329 | 63,026 | - | 15.3 | 20,360 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 21 Sep 2022 | 1,023 | 215,422 | - | 15.1 | 15,413 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 21 Sep 2022 | 3,402 | 216,445 | - | 15.1 | 51,425 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 21 Sep 2022 | 3,341 | 20,716 | - | 15.1 | 50,393 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 939 | 24,625 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2022 | 3,341 | 25,564 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 21 Sep 2022 | 939 | 20,716 | - | 15.1 | 14,167 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Sep 2022 | 939 | 21,655 | - | 2.1 | 1,972 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 21 Sep 2022 | 3,341 | 24,057 | - | 2.1 | 7,016 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 21 Sep 2022 | 3,275 | 65,373 | - | 15.1 | 49,537 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 21 Sep 2022 | 1,018 | 64,355 | - | 15.1 | 15,341 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 15 Sep 2022 | 200 | 219,847 | - | 15.0 | 3,008 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2022 | 106 | 28,905 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 15 Sep 2022 | 106 | 20,822 | - | 2.1 | 223 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 15 Sep 2022 | 106 | 20,716 | - | 15.0 | 1,591 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 15 Sep 2022 | 100 | 68,648 | - | 15.0 | 1,501 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 08 Sep 2022 | 1,100 | 220,735 | - | 15.2 | 16,673 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Sep 2022 | 688 | 220,047 | - | 15.1 | 10,366 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Sep 2022 | 800 | 20,716 | - | 15.1 | 12,054 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 08 Sep 2022 | 800 | 21,516 | - | 2.1 | 1,680 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 08 Sep 2022 | 1,221 | 21,937 | - | 2.1 | 2,564 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 08 Sep 2022 | 1,221 | 20,716 | - | 15.1 | 18,478 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 800 | 29,011 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 1,221 | 29,811 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 08 Sep 2022 | 865 | 68,748 | - | 15.1 | 13,031 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 08 Sep 2022 | 912 | 69,613 | - | 15.1 | 13,814 | Common Stock |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 15,125 | 221,835 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,503 | 16,489 | - | 0 | Common Stock | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,172 | 20,716 | - | 0 | Common Stock | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,632 | 70,525 | - | 0 | Common Stock | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,794 | 162,144 | - | 0 | Common Stock | |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.51 per share. | 29 Aug 2022 | 505 | 207,096 | - | 13.5 | 6,822 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 29 Aug 2022 | 171 | 206,710 | - | 12 | 2,052 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 29 Aug 2022 | 190 | 206,881 | - | 12 | 2,280 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 29 Aug 2022 | 25 | 207,071 | - | 14 | 350 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 29 Aug 2022 | 1,109 | 207,601 | - | 12.6 | 13,931 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.52 per share. | 24 Aug 2022 | 2,817 | 12,838 | - | 13.5 | 38,093 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 1,117 | 108,807 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.18 per share. | 24 Aug 2022 | 1,551 | 10,986 | - | 14.2 | 21,986 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 24 Aug 2022 | 301 | 12,537 | - | 14.2 | 4,282 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 24 Aug 2022 | 1,117 | 15,655 | - | 2.1 | 2,346 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 19 Aug 2022 | 8,529 | 16,144 | - | 13.1 | 111,530 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 1,403 | 109,924 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 117 | 111,327 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 4,452 | 111,444 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.09 per share. | 19 Aug 2022 | 2,909 | 14,538 | - | 13.1 | 38,080 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 19 Aug 2022 | 1,403 | 17,447 | - | 2.1 | 2,946 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 19 Aug 2022 | 217 | 16,044 | - | 13.0 | 2,822 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 19 Aug 2022 | 117 | 16,261 | - | 2.1 | 246 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 19 Aug 2022 | 4,452 | 24,673 | - | 2.1 | 9,349 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 100 | 115,896 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 100 | 115,996 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 100 | 116,096 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 16 Aug 2022 | 200 | 20,221 | - | 13 | 2,600 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 16 Aug 2022 | 100 | 20,441 | - | 2.1 | 210 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 16 Aug 2022 | 200 | 20,341 | - | 13.1 | 2,614 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 16 Aug 2022 | 100 | 20,541 | - | 2.1 | 210 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 16 Aug 2022 | 200 | 20,441 | - | 13 | 2,600 | Common Stock |
| Kory J. Wentworth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 16 Aug 2022 | 100 | 20,641 | - | 2.1 | 210 | Common Stock |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jul 2022 | 2,000 | 208,710 | - | 12 | 24,000 | Common Stock |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 90,750 | 90,750 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 33,019 | 33,019 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 31,032 | 31,032 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 33,788 | 33,788 | - | - | Stock Option (Right to Buy) | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 34,763 | 34,763 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jun 2022 | 4,000 | 210,710 | - | 12 | 48,000 | Common Stock |
| Nathan J. Dowden | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 27 Jun 2022 | 7,714 | 64,893 | - | 13 | 100,282 | Common Stock |
| John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Todd A. Foley | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Carole L. Nuechterlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 181,500 | 181,500 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,250 | 214,710 | - | 0 | Common Stock | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 66,038 | 66,038 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,006 | 20,541 | - | 0 | Common Stock | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 10,344 | 15,544 | - | 0 | Common Stock | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 62,063 | 62,063 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,263 | 72,607 | - | 0 | Common Stock | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 67,575 | 67,575 | - | - | Stock Option (Right to Buy) | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,588 | 156,350 | - | 0 | Common Stock | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 69,525 | 69,525 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 13 Jan 2022 | 10,000 | 184,460 | - | 1.7 | 17,400 | Common Stock |
| Dipal Doshi | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 10,000 | 399,989 | - | - | Stock Option (Right to Buy) | |
| John F. Crowley | Director | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 12 Jan 2022 | 5,000 | 5,000 | - | 9.7 | 48,575 | Common Stock |
| Nerissa C. Kreher | Chief Medical Officer | 29 Dec 2021 | 5,200 | 142,722 | - | - | Stock Option (Right to Buy) | ||
| Nerissa C. Kreher | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 29 Dec 2021 | 5,200 | 5,200 | - | 2.1 | 10,920 | Common Stock |
| Todd A. Foley | Director, Ten Percent Owner | 02 Nov 2021 | 3,816,760 | 3,816,760 | - | - | Common Stock | ||
| Todd A. Foley | Director, Ten Percent Owner | 02 Nov 2021 | 3,683,241 | 0 | - | - | Series B Preferred Stock | ||
| Todd A. Foley | Director, Ten Percent Owner | 02 Nov 2021 | 27,617,675 | 0 | - | - | Series A Preferred Stock | ||
| Todd A. Foley | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 02 Nov 2021 | 100,000 | 4,425,784 | - | 20 | 2,000,000 | Common Stock |
| Todd A. Foley | Director, Ten Percent Owner | 02 Nov 2021 | 509,024 | 4,325,784 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 564,217 | 564,217 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,140 | 882,357 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 254,512 | 3,276,022 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 2,371,739 | 3,021,510 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,140 | 0 | - | - | Series B Preferred Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 254,512 | 0 | - | - | Series B Preferred Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,616 | 649,771 | - | - | Common Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 564,217 | 0 | - | - | Series A Preferred Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 2,371,739 | 0 | - | - | Series A Preferred Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | 02 Nov 2021 | 318,616 | 0 | - | - | Series Seed Preferred Stock | ||
| Kush M. Parmar | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 02 Nov 2021 | 250,000 | 1,132,357 | - | 20 | 5,000,000 | Common Stock |
| John F. Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Todd A. Foley | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 23,552 | 23,552 | - | - | Stock Option (Right to Buy) | |
| Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 184,821 | 184,821 | - | - | Stock Option (Right to Buy) | |
| Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Carole L. Nuechterlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 23,552 | 23,522 | - | - | Stock Option (Right to Buy) | |
| Kush M. Parmar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 23,552 | 23,552 | - | - | Stock Option (Right to Buy) | |
| Kory J. Wentworth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 72,012 | 72,012 | - | - | Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 72,012 | 72,012 | - | - | Stock Option (Right to Buy) | |
| Nathan J. Dowden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 95,148 | 95,148 | - | - | Stock Option (Right to Buy) | |
| Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 243,639 | 243,639 | - | - | Stock Option (Right to Buy) |